Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Depravity of the False Flag

"Never let a good crisis go to waste." —Sir Winston Churchill My late older brother Donnie was a quasi-anarchist tax collector for the Canadian government who self-educated himself and then morphed from a grumbling, cynical security guard/starving artist to a very succe...

Syros Pharma Teams Up with Global Blood Therapeutics to Fight Sickle Cell Disease

Syros Pharmaceuticals' shares rose 20% today after the firm reported that it entered into a collaboration agreement with Global Blood Therapeutics for development of therapies for sickle cell disease and beta thalassemia that could result in payments to Syros as high as $315 m...

Smart City Security Takes Shape in Mexico City with Lighting and Analytics Collaboration

The two firms are bringing together lighting, cameras and analytic technology. Energetika, an international firm based in Mexico City that provides intelligent lighting solutions, is collaborating with VSBLTY Groupe Technologies Corp. (VSBY:CSE; VSBGF:OTC; 5VS:FRA) ,...

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...

Intra-Cellular Therapies Shares Rise 200% on FDA Approval of Adult Schizophrenia Drug

Shares of Intra-Cellular Therapies opened greater than 100% higher today after the company reported that the FDA approved its antipsychotic CAPLYTA® (lumateperone) drug for the treatment of schizophrenia in adults. This morning a biopharmaceutical company foc...

The First City of Capitalism: Silver’s Time to Shine

Last Updated on “For the powerful emperor, for the wise king, this lofty mountain of silver could conquer the world.” -King Felipe II 1561. Powered by an intricate set of 22 dams, 140 mills churned out silver. It was an impress...

Manchester United Investors Get a Kick from Silver Lake's Investment in Rival Football Club

Shares of Manchester United traded 12% higher today after private investment firm Silver Lake Partners announced that it is acquiring a $500 million stake in City Football Group, owner of the reigning English Premier League champions Manchester City. Today, shares of ...

Invasive Species

Invasive species: Any kind of living organism—an amphibian (like the cane toad), plant, insect, fish, fungus, bacteria, or even an organism's seeds or eggs—that is not native to an ecosystem and causes harm. They can harm the environment, the economy, or even human he...

Lithium plant developer zeros in on Thunder Bay refinery site

Ian Ross, Northern Ontario BusinessAvalon Advanced Materials making purchase offer on city property to start refinery construction by 2023The developer of a much-anticipated lithium processing...

As Drone Market Changes, This Small Cap Offers Opportunities

In my first write up about drones, I used the phrase "The Drones are coming." Perhaps now it is more appropriate "The Drones are multiplying like rabbits." The FAA announced that there were more than 122,000 commercial drone pilots in early 2018. Combined with the 87...
1 2 3 4 5 6 7 8 9 10 ...